DNA strand

The Preclinical Research Resource (PRR) has a cancer translational research-centered mission to facilitate the use of patient-derived xenograft (PDX) models, genetically engineered mouse models (GEMMs), and other relevant mouse cancer models in preclinical drug development and identification of relevant biomarkers for treatment selection and evaluation.

We provide start-to-finish services for in vivo experimentation, including experimental design consultation, tumor cell transplant, tumor growth monitoring and imaging, preparation of therapeutic agents, harvested tissues, and interpretation of results.

    Contact

    Preclinical Research Resource Director
    David H Lum, PhD
    david.lum@hci.utah.edu
    801-213-5663

    Associate Director
    Kate Modzelewska, PhD
    Kate.Modzelewska@hci.utah.edu

    Lab Contact
    prr@hci.utah.edu

    Governance

    HCI Senior Director Oversight
    Martin McMahon, PhD

    Faculty Advisory Committee Chair
    Sheri Holmen, PhD

    Faculty Advisory Committee Members
    Neeraj Agarwal, MD
    Ignacio Garrido-Laguna, MD, PhD
    Margit Janat-Amsbury, MD, PhD
    Charles Murtaugh, PhD
    Eric Snyder, MD, PhD
    Alana Welm, PhD